$XLRN ACCELERON PHARMA INC Insider Trading Week 50/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC in week 50/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 3.88 | 15,000 | 58,200 | 36,240 | |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 3.88 | 15,000 | 58,200 | 15,000 | 0 to 15 K |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 1.80 | 5,825 | 10,485 | 7,300 | |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 0.92 | 3,985 | 3,666 | 0 | |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 1.80 | 5,825 | 10,485 | 37,700 | 31.9 K to 37.7 K (+18.27 %) |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 0.92 | 3,985 | 3,666 | 31,875 | 27.9 K to 31.9 K (+14.29 %) |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Option Exercise | M | 0.48 | 4,000 | 1,920 | 32,000 | |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 35,500 | |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 40.19 | 1,000 | 40,190 | 20,500 | 21.5 K to 20.5 K (-4.65 %) |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 40.60 | 200 | 8,120 | 20,004 | 20.2 K to 20 K (-0.99 %) |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 40.13 | 3,800 | 152,494 | 20,204 | 24 K to 20.2 K (-15.83 %) |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Buy | M | 0.48 | 4,000 | 1,920 | 24,004 | 20 K to 24 K (+20.00 %) |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Buy | M | 3.88 | 2,000 | 7,760 | 20,004 | 18 K to 20 K (+11.11 %) |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 15,000 | 58,200 | 110,751 | |
| Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 15,000 | 58,200 | 25,000 | 10 K to 25 K (+150.00 %) |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 23,867 | 0 | 28,734 | 4.9 K to 28.7 K (+490.38 %) |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | J | 0.00 | 23,867 | 0 | 251 | 24.1 K to 251 (-98.96 %) |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 13,136 | 0 | 13,136 | 0 to 13.1 K |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | J | 0.00 | 13,136 | 0 | 24,118 | 37.3 K to 24.1 K (-35.26 %) |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 712 | 0 | 37,254 | 36.5 K to 37.3 K (+1.95 %) |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 36,542 | 0 | 36,542 | 0 to 36.5 K |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 3,187 | 0 | 3,187 | 0 to 3.2 K |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 51,163 | 0 | 51,163 | 0 to 51.2 K |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | J | 0.00 | 60,496 | 0 | 30,248 | 90.7 K to 30.2 K (-66.67 %) |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | J | 0.00 | 500,421 | 0 | 500,420 | 1 M to 500.4 K (-50.00 %) |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 0.92 | 4,000 | 3,680 | 3,500 | |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 41.72 | 2,500 | 104,300 | 0 | 2.5 K to 0 (-100.00 %) |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 40.72 | 1,500 | 61,080 | 2,500 | 4 K to 2.5 K (-37.50 %) |
| Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 0.92 | 4,000 | 3,680 | 4,000 | 0 to 4 K |
| Dec 15 2014 | XLRN | ACCELERON PHARMA I ... | MCGUIRE TERRANCE | Director | Sell | J | 0.00 | 403,166 | 0 | 2,218,572 | 2.6 M to 2.2 M (-15.38 %) |